Search
for
Sort by
Research 61–90 of 1000+
- Dermatologic adverse events in EGFR-TKIs: A real-world analysis.
- Side Effects and Adverse Events After Treatment With Teprotumumab for Thyroid Eye Disease: A Retrospective Observational Case Series
- Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma
- Pharmacovigilance-based drug repurposing: searching for putative drugs with hypohidrosis or anhidrosis adverse events for use against hyperhidrosis
- Dipyridamole-Associated Shock and Pulmonary Edema; Oxcarbazepine-Induced Resistant Ventricular Fibrillation; Finasteride-Induced Pseudoporphyria; Suicidal Ideation Associated with Asenapine; Rediscovering Adverse Anticholinergic Effects; Prevalence of Adverse Drug Events in Ambulatory Care
- Post-Exposure Syndromes as State-Space Trapping: A set-theoretic perspective on PSSD and the post-exposure family.
- Post-Exposure Syndromes as State-Space Trapping: A set-theoretic perspective on PSSD and the post-exposure family.
- Controversies: Is Finasteride Safety Data Adequately Reported in Published Trials?
- How routine pharmacovigilance failed to identify finasteride’s persistent sexual side effects
- Implementing patient safety and quality improvement in dermatology. Part 1: Patient safety science
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Cognitive dysfunction following finasteride use: a disproportionality analysis of the global pharmacovigilance database
- Persistent Sexual Dysfunction and Suicidal Ideation in Young Men Treated with Low-Dose Finasteride: A Pharmacovigilance Study
- 0439 Temporal–phenotype signatures of alopecia associated with GLP-1–based therapies: A PRISMA-ScR scoping review
- Finasteride Use: Evaluation of Depression and Suicide Risk
- Assessing the safety of topical minoxidil through disproportionality analysis of FAERS reports
- Sun behaviors and quality of life after first cutaneous melanoma diagnosis
- Sun protection policies and behaviors among U.S. child care centers
- Association of 5-α reductase inhibitors and sexual dysfunction: A RADAR report
- Adverse events of the thyroid peroxidase inhibitor methimazole in the treatment of hyperthyroidism: a comprehensive analysis from the first quarter of 2004 to the first quarter of 2025
- En pacientes jóvenes, el uso de finasteride podría asociarse con mayor riesgo de ansiedad, depresión y eventos adversos relacionados con el suicidio
- Neuropsychiatric Adverse Events of Montelukast: An Analysis of Real-World Datasets and drug−gene Interaction Network
- Adverse events with finasteride or dutasteride: FAERS
- Adverse events associated with aromatase inhibitors: an analysis of real-world datasets and drug-gene interaction network
- Supplementary Material for: Finasteride and Suicide: A Postmarketing Case Series
- 0348 Adverse event reports of alopecia for sunscreen ingredients and branded products
- Image3_Neuropsychiatric Adverse Events of Montelukast: An Analysis of Real-World Datasets and drug−gene Interaction Network.TIFF
- Association of Hair Loss With Suicidality and Psychological Adverse Events vs Finasteride Use—Reply
- Sunscreen: Cosmetic or medical therapy?
- Clinical Management of Cutaneous Adverse Events in Patients on Chemotherapy: A National Consensus Statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology